Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma
Journal Article
·
· J. Nucl. Med.; (United States)
OSTI ID:6593133
Patients with lymphomas are conventionally imaged with (/sup 67/Ga)citrate for tumor detection and determination of dissemination. Fluorine-18-2-fluoro-2-deoxy-D-glucose (( /sup 18/F)FDG) is a radiopharmaceutical that accumulates into tissues where glucose utilization is enhanced, such as tumors. Six cancer patients (five non-Hodgkin's lymphomas, one endodermal retroperitoneal sinus carcinoma) were imaged with (/sup 18/F)FDG and (/sup 67/Ga)citrate whole-body scintigraphies in order to compare the sensitivities of these two tumor imaging radiopharmaceuticals. Among the five untreated lymphoma patients, two /sup 67/Ga scans and four (/sup 18/F)FDG scans were positive; in the patient with the retroperitoneal carcinoma who had a positive (/sup 18/F)FDG scan before treatment, both scans were negative after treatment. Fluorine-18 FDG may be a more sensitive tumor-detecting radiopharmaceutical for non-Hodgkin's lymphoma than (/sup 67/Ga)citrate.
- Research Organization:
- Turku Univ. Central Hospital, Finland
- OSTI ID:
- 6593133
- Journal Information:
- J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 3; ISSN JNMEA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Scintigraphic evaluation of lymphoma: a comparative study of /sup 67/Ga-citrate and /sup 111/In-bleomycin
Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study
The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis
Journal Article
·
Wed May 25 00:00:00 EDT 1977
· J. Biol. Chem.; (United States)
·
OSTI ID:7259882
Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study
Journal Article
·
Sat Jun 01 00:00:00 EDT 1991
· Journal of Nuclear Medicine; (United States)
·
OSTI ID:5594459
The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis
Journal Article
·
Sun Mar 31 23:00:00 EST 1991
· Journal of Nuclear Medicine; (USA)
·
OSTI ID:5683535
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ALDEHYDES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
CARBOHYDRATES
CARCINOMAS
COMPARATIVE EVALUATIONS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
FLUORINE 18
FLUORINE ISOTOPES
GALLIUM 67
GALLIUM ISOTOPES
GLUCOSE
HEXOSES
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
LYMPHOMAS
MONOSACCHARIDES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOPHARMACEUTICALS
SACCHARIDES
SCINTISCANNING
SENSITIVITY ANALYSIS
WHOLE-BODY COUNTING
62 RADIOLOGY AND NUCLEAR MEDICINE
ALDEHYDES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
CARBOHYDRATES
CARCINOMAS
COMPARATIVE EVALUATIONS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
FLUORINE 18
FLUORINE ISOTOPES
GALLIUM 67
GALLIUM ISOTOPES
GLUCOSE
HEXOSES
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
LYMPHOMAS
MONOSACCHARIDES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOPHARMACEUTICALS
SACCHARIDES
SCINTISCANNING
SENSITIVITY ANALYSIS
WHOLE-BODY COUNTING